JPMorgan Names Top 3 Picks Among Auto Parts Stocks

JPMorgan identified Adient (ADNT), Dana (DAN), and Gentherm (THRM) as top auto parts stock picks, citing self-help initiatives and structural improvements. The firm rates all three Overweight, noting discounts to peers and buyback capacity despite near-term pressures. Adient faces softer 2027 revenue but expects margin expansion. Dana benefits from commercial-vehicle demand recovery and pending deal synergies. Gentherm sees growth from comfort content and Modine combination.

Original reporting
Published Nov 12, 2026, 7:10 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 12, 2026, 7:17 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$ADNT
Bullish
high confidence
Mentioned
$ADNT · $DAN · $THRM
Relevance
6/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$ADNTBullishMed
01

Why it matters

Analyst overweight ratings could trigger short‑term buying pressure across the highlighted stocks.

02

Market read

The ratings may influence investor positioning in the auto parts sector, potentially lifting the three named stocks.

03

What to watch

Execution risk of the ETN Mobility deal and the sustainability of margin improvements.

Relevance 6/10Novelty 6/10Timing: pre‑market today

Background

JPMorgan released its top three auto parts stock picks, providing rating upgrades and strategic rationale.

Company-level read

Ticker impact

$ADNTBullishHigh confidence
Context

JPMorgan rates Adient Overweight, citing self‑help initiatives and onshoring benefits despite softer 2027 revenue guidance.

Expected impact

likely upward pressure as investors price in the overweight rating and buyback capacity.

Evidence & confidence

Analyst upgrade with clear thesis and buyback capacity can prompt short‑term buying.

$DANBullishHigh confidence
Context

JPMorgan rates Dana Overweight, highlighting clean earnings‑growth profile and pending ETN Mobility deal expected to close in early 2027.

Expected impact

moderate upside as the market prices in the deal and margin expansion outlook.

Evidence & confidence

Overweight rating plus deal catalyst can drive buying pressure.

$THRMBullishHigh confidence
Context

JPMorgan is Overweight on Gentherm, noting growth from comfort content, margin self‑help and Modine combination synergies.

Expected impact

potential modest upside as investors weigh the growth thesis and buyback catalyst.

Evidence & confidence

Analyst endorsement with buyback catalyst can attract demand.

Market effects

Highlights broader auto parts sector valuation opportunities amid onshoring trends.

North American onshoring focus may benefit regional suppliers.

Signals potential re‑rating of auto parts stocks globally.

Counterpoint

Peers may argue that sector headwinds and inflation could outweigh the upside from buybacks.

Key entities

  • JPMorgan

    Provides the ratings and investment thesis.

  • Adient

    Auto parts supplier receiving an Overweight rating.

  • Dana

    Auto parts maker highlighted for its earnings profile and pending deal.

  • Gentherm

    Auto parts firm noted for growth and buyback catalyst.

Related articles

$ADNTHighAI 8/10

Adient PLC (ADNT) (Q4 2026) Earnings Call Highlights: Solid Fiscal 2026 Results

Adient PLC (ADNT) reported fiscal 2026 results but anticipates challenges in 2027, including a 1% decline in global vehicle production and margin compression in China. The company expects free cash flow to drop to over $100 million from $222 million due to lower volumes and higher costs. CEO Jerome Dorlack highlighted ongoing issues in EMEA and Americas, with a focus on cost management and cash flow optimization.

$ADNTMed

Adient reports dip to annual profit

Adient reported a Q4 FY26 GAAP net loss of $47M, down from $18M net income in Q4 2025, with revenue flat at $3.7B. Adjusted net income was $40M, slightly down from $42M. Full-year revenue rose 4% to €15.168B, while net income fell 9% to $147M. Regional performance varied, with strong results in the Americas and China, but weaker performance in EMEA and the Rest of Asia.

$ADNTMed

Adient Q4 Earnings Call Highlights

Adient (ADNT) reported Q4 earnings, citing cost pressures from tariffs, fuel, and labor. It forecasts $100M+ free cash flow for 2027, down from 2026. The company repurchased $100M in shares and increased its authorization by $400M. CEO Dorlack highlighted growth in China, challenges in Europe, and new business wins, including a $400M+ onshoring backlog. CFO transition is planned for November 16.

$ADNTMedAI 8/10

Adient plc Q4 2026 Earnings Call Summary

Adient plc reported FY2026 revenue of $15.2B, up 4%, with adjusted EBITDA flat at $884M. Challenges included operational inefficiencies in the Americas and Middle East disruptions. China outperformed with 60% domestic OEM mix. FY2027 guidance projects revenue of $14.8B-$15B and adjusted EBITDA of $900M-$925M. The company plans $100M in share repurchases and a Tax Benefits Preservation Plan.

$ADNTHighAI 8/10

Adient (ADNT) Q4 2026 Earnings Call Transcript

Adient (ADNT) reported fiscal 2026 revenue of $15.2B, up 4% YoY, with adjusted EBITDA of $884M, flat YoY. The company generated $222M in free cash flow, repurchased $100M in shares, and reduced debt by $35M. Despite industry challenges, Adient secured new business with multiple automakers and expects growth in fiscal 2027.